NM_001034853.2:c.223A>G
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001034853.2(RPGR):c.223A>G(p.Ile75Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0139 in 1,208,675 control chromosomes in the GnomAD database, including 224 homozygotes. There are 5,304 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★★).
Frequency
Consequence
NM_001034853.2 missense
Scores
Clinical Significance
Conservation
Publications
- retinitis pigmentosa 3Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- RPGR-related retinopathyInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- primary ciliary dyskinesia-retinitis pigmentosa syndromeInheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- cone-rod dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- retinitis pigmentosaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- macular degeneration, X-linked atrophicInheritance: XL Classification: LIMITED Submitted by: G2P
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| RPGR | ENST00000645032.1 | c.223A>G | p.Ile75Val | missense_variant | Exon 3 of 15 | NM_001034853.2 | ENSP00000495537.1 | |||
| ENSG00000250349 | ENST00000465127.1 | c.172-343244T>C | intron_variant | Intron 3 of 8 | 5 | ENSP00000417050.1 |
Frequencies
GnomAD3 genomes AF: 0.0315 AC: 3538AN: 112158Hom.: 84 Cov.: 23 show subpopulations
GnomAD2 exomes AF: 0.0159 AC: 2909AN: 183460 AF XY: 0.0147 show subpopulations
GnomAD4 exome AF: 0.0121 AC: 13283AN: 1096466Hom.: 139 Cov.: 28 AF XY: 0.0118 AC XY: 4286AN XY: 362086 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0316 AC: 3548AN: 112209Hom.: 85 Cov.: 23 AF XY: 0.0296 AC XY: 1018AN XY: 34373 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:4Other:1
- -
- -
- -
- -
This variant is associated with the following publications: (PMID: 22995991, 22025579, 9399904, 27884173) -
not specified Benign:3
- -
- -
p.Ile75Val in exon 3 of RPGR: This variant is not expected to have clinical sign ificance because it has been identified in 8.9% (343/3833) of African American c hromosomes from a broad population by the NHLBI Exome Sequencing Project (http:/ /evs.gs.washington.edu/EVS; dbSNP rs111631988). -
Primary ciliary dyskinesia Benign:2
- -
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
X-linked cone-rod dystrophy 1;C1845667:Retinitis pigmentosa 3;C2749137:Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness;C3151784:Macular degeneration, X-linked atrophic Benign:1
- -
RPGR-related retinopathy Benign:1
NM_001034853.2(RPGR):c.223A>G (p.Ile75Val) is a missense variant predicted to cause substitution of isoleucine by valine at amino acid 75. This variant is present in gnomAD v.4.1.0 at a frequency of 0.01338 among hemizygous individuals, with 5304 variant alleles / 396,459 total hemizygous alleles, which is higher than the ClinGen X-linked IRD VCEP BA1 threshold of >0.000005 (BA1). The computational predictor REVEL gives a score of 0.218, which is below the ClinGen X-linked IRD VCEP threshold of <0.290 and predicts a non-damaging effect on RPGR function. However, the splicing impact predictor SpliceAI gives a delta score of 0.12 for acceptor gain, which falls in the intermediate range above the ClinGen X-linked IRD VCEP recommended BP4 threshold of <0.1 but lower than the PP3 threshold of >0.2, so neither in silico code is met. In summary, this variant is classified as benign for RPGR-related retinopathy based on the ClinGen X-linked Inherited Retinal Disease Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for RPGR Version 1.0.0; BA1. (date of approval 05/16/2025). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at